Projects funded by the NCN


Information on the principal investigator and host institution

Information of the project and the call

Keywords

Equipment

Delete all

Effects of a cancer metabolite on immune response

2020/39/B/NZ6/03513

Keywords:

immune response cancer metabolism

Descriptors:

  • NZ6_001:

Panel:

NZ6 - Human and animal immunology and infection: immunity, immune disorders, immunotherapy, infectious and invasive diseases, microbiology, transplantology, allergology

Host institution :

Warszawski Uniwersytet Medyczny, Wydział Lekarski

woj. mazowieckie

Other projects carried out by the institution 

Principal investigator (from the host institution):

dr Abdessamad Zerrouqi 

Number of co-investigators in the project: 6

Call: OPUS 20 - announced on 2020-09-15

Amount awarded: 2 596 658 PLN

Project start date (Y-m-d): 2021-07-08

Project end date (Y-m-d): 2025-07-07

Project duration:: 48 months (the same as in the proposal)

Project status: Project completed

Project description

Download the project description in a pdf file

Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.

Information in the final report

  • Publication in academic press/journals (1)
  • Articles in post-conference publications (1)
  1. Potassium/sodium cation carriers robustly up-regulate CD20 antigen by targeting MYC, and synergize with anti-CD20 immunotherapies to eliminate malignant B cells.
    Authors:
    Torun A., Zdanowicz A., Miazek-Zapala N., Zapala P., Pradhan B., Jedrzejczyk M., Ciechanowicz A., Pilch Z., Skorzynski M., Słabicki M., Rymkiewicz G., Barankiewicz J., Martines C., Laurenti L., Struga M., Winiarska M., Golab J., Kucia M., Ratajczak M.Z., Huczynski A., Calado D.P., Efremov D.G., Zerrouqi A., and Pyrzynska B.
    Academic press:
    Haematologica (rok: 2024, tom: Haematologica Early view Dec 19, 2024, strony: 46053), Wydawca: Ferrata-Storti Foundation
    Status:
    Published
    DOI:
    10.3324/haematol.2024.285826 - link to the publication
  1. Improvement of the anti-tumor activity of NK cells and the efficacy of anti-CD20 monoclonal antibodies in the therapy of B cell-derived malignancies.
    Authors:
    Zerrouqi A., Zdanowicz A., Torun A., Ciechanowicz A., Pradhan B., Rymkiewicz G., Efremov D., and Pyrzynska B.
    Conference:
    Cancer Research, Vol. 84 (6_Suppl) (rok: 2024, tom: AACR Annual Meeting 2024, strony: Abstract no 1344), Wydawca: American Association for Cancer Research
    Data:
    konferencja 5-10/04/2024
    Status:
    Published
    DOI:
    10.1158/1538-7445.AM2024-1344 - link to the publication